Prospects and Limitations Related to the Use of MicroRNA as a Biomarker of Epilepsy in Children: A Systematic Review

Epilepsy is one of the most common neurological diseases in children. There is an unmet need for new objective methods that would facilitate and accelerate the diagnostic process, thus improving the prognosis. In many studies, the participation of microRNA in epileptogenesis has been confirmed. Ther...

Full description

Bibliographic Details
Main Authors: Beata Rzepka-Migut, Justyna Paprocka
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Life
Subjects:
Online Access:https://www.mdpi.com/2075-1729/11/1/26
id doaj-a9b889bd158340acabd11b520b10bb9c
record_format Article
spelling doaj-a9b889bd158340acabd11b520b10bb9c2021-01-05T00:01:11ZengMDPI AGLife2075-17292021-01-0111262610.3390/life11010026Prospects and Limitations Related to the Use of MicroRNA as a Biomarker of Epilepsy in Children: A Systematic ReviewBeata Rzepka-Migut0Justyna Paprocka1Department of Pediatric Neurology and Pediatrics, St. Queen Jadwiga’s Regional Clinical Hospital No. 2, 35-301 Rzeszów, PolandDepartment of Pediatric Neurology, Faculty of Medical Science in Katowice, Medical University of Silesia, 40-752 Katowice, PolandEpilepsy is one of the most common neurological diseases in children. There is an unmet need for new objective methods that would facilitate and accelerate the diagnostic process, thus improving the prognosis. In many studies, the participation of microRNA in epileptogenesis has been confirmed. Therefore, it seems to be a promising candidate for this role. Scientists show the possibility of using microRNAs as diagnostic and predictive biomarkers as well as novel therapeutic targets. Children with epilepsy would benefit particularly from the use of this innovative method. However, the number of studies related to this age group is very limited. This review is based on 10 studies in children and summarizes the information collected from studies on animal models and the adult population. A total of 136 manuscripts were included in the analysis. The aim of the review was to facilitate the design of studies in children and to draw attention to the challenges and traps related to the analysis of the results. Our review suggests a high potential for the use of microRNAs and the need for further research.https://www.mdpi.com/2075-1729/11/1/26microRNAmiRNAepilepsychildrenbiomarkerprognosis
collection DOAJ
language English
format Article
sources DOAJ
author Beata Rzepka-Migut
Justyna Paprocka
spellingShingle Beata Rzepka-Migut
Justyna Paprocka
Prospects and Limitations Related to the Use of MicroRNA as a Biomarker of Epilepsy in Children: A Systematic Review
Life
microRNA
miRNA
epilepsy
children
biomarker
prognosis
author_facet Beata Rzepka-Migut
Justyna Paprocka
author_sort Beata Rzepka-Migut
title Prospects and Limitations Related to the Use of MicroRNA as a Biomarker of Epilepsy in Children: A Systematic Review
title_short Prospects and Limitations Related to the Use of MicroRNA as a Biomarker of Epilepsy in Children: A Systematic Review
title_full Prospects and Limitations Related to the Use of MicroRNA as a Biomarker of Epilepsy in Children: A Systematic Review
title_fullStr Prospects and Limitations Related to the Use of MicroRNA as a Biomarker of Epilepsy in Children: A Systematic Review
title_full_unstemmed Prospects and Limitations Related to the Use of MicroRNA as a Biomarker of Epilepsy in Children: A Systematic Review
title_sort prospects and limitations related to the use of microrna as a biomarker of epilepsy in children: a systematic review
publisher MDPI AG
series Life
issn 2075-1729
publishDate 2021-01-01
description Epilepsy is one of the most common neurological diseases in children. There is an unmet need for new objective methods that would facilitate and accelerate the diagnostic process, thus improving the prognosis. In many studies, the participation of microRNA in epileptogenesis has been confirmed. Therefore, it seems to be a promising candidate for this role. Scientists show the possibility of using microRNAs as diagnostic and predictive biomarkers as well as novel therapeutic targets. Children with epilepsy would benefit particularly from the use of this innovative method. However, the number of studies related to this age group is very limited. This review is based on 10 studies in children and summarizes the information collected from studies on animal models and the adult population. A total of 136 manuscripts were included in the analysis. The aim of the review was to facilitate the design of studies in children and to draw attention to the challenges and traps related to the analysis of the results. Our review suggests a high potential for the use of microRNAs and the need for further research.
topic microRNA
miRNA
epilepsy
children
biomarker
prognosis
url https://www.mdpi.com/2075-1729/11/1/26
work_keys_str_mv AT beatarzepkamigut prospectsandlimitationsrelatedtotheuseofmicrornaasabiomarkerofepilepsyinchildrenasystematicreview
AT justynapaprocka prospectsandlimitationsrelatedtotheuseofmicrornaasabiomarkerofepilepsyinchildrenasystematicreview
_version_ 1724348793211584512